Presentation is loading. Please wait.

Presentation is loading. Please wait.

Office of Science and Technology Center for Devices and Radiological Health, FDA William A. Herman eHealth Technologies and the FDA.

Similar presentations


Presentation on theme: "Office of Science and Technology Center for Devices and Radiological Health, FDA William A. Herman eHealth Technologies and the FDA."— Presentation transcript:

1 Office of Science and Technology Center for Devices and Radiological Health, FDA William A. Herman eHealth Technologies and the FDA

2 CDRH TECHNOLOGY FORECAST Computer-related Technology Computer-related Technology Molecular Medicine Molecular Medicine Home- and Self-care Home- and Self-care Minimally Invasive Procedures Minimally Invasive Procedures Device/Drug Products Device/Drug Products Organ Replacements and Assists Organ Replacements and Assistshttp://www.fda.gov/cdrh/ost/trends/toc.html Emerging Technology Trends

3 Robert AbodeelyJames Allen Clement Bezold Pfizer - MTGAMA Institute for Alternative Futures Stephen P. BruttigJoseph F. Coates Gilbert B. Devey U.S. ArmyCoates and Jarrett NSF Henry S. EdenDon Giddens Harry Handlesman NIHGa. Inst. Of Tech. AHCPR Peter KatonaIan H. Leverton Barbara McNeil Whitaker FoundationKaiser-Permanente Harvard University Anthony J. MontagnoloRobert M. Nerem Charles H. Swanson ECRI Ga. Inst. Of Tech. Medtronic Survey Participants

4 Medical Device Technology Drivers Demographic trends Economic trends Technology trends

5 Computer-related device trends Substantial new product development 5-10 yrs Substantial new product development 5-10 yrs Integrated patient medical information systems Integrated patient medical information systems Smart cards Smart cards Computer-aided medical decisionmaking Computer-aided medical decisionmaking Smart artificial organ implants Smart artificial organ implants Miniaturized biosensors & sensor fusion Miniaturized biosensors & sensor fusion Customized microprocessor devices Customized microprocessor devices

6 Homecare technology trends Substantial new product development 5-10 yrs Substantial new product development 5-10 yrs Limited expectations for advanced technologies Limited expectations for advanced technologies Monitoring -- blood, urine, drug concentrations Monitoring -- blood, urine, drug concentrations Simplified drug delivery systems Simplified drug delivery systems Telemedicine Telemedicine Smart devices Smart devices

7 Home Care Technologies for the 21 st Century NSF-FDA Workshop NSF-FDA Workshop participants participants - Industry - Academia - Academia - Government - Government - Clinicians - Clinicians - Providers - Providers

8 21 st Century Home Care Technology Prevention-oriented devices Prevention-oriented devices Consumer health model Consumer health model Noninvasive sensors Noninvasive sensors Smart devices Smart devices Customized products, flexible configurations Customized products, flexible configurations Data analysis tools for medical decisions Data analysis tools for medical decisions Electronic patient records Electronic patient records Wearable products Wearable products Wireless net-linked systems Wireless net-linked systems

9 US Food & Drug Administration Center for Drugs Center for Food Safety and Applied Nutrition Center for Biologics Center for Veterinary Medicine Center for Devices and Radiological Health National Center for Toxicological Research Office of Regional Affairs

10 CDRH Focus Ensuring the safety and effectiveness of medical devices

11 FDAs Mandate for Regulation Medical Device Amendments (1976) Regulations implementing FD&C Act - Title 21 Code of Federal Regulations (21CFR) Parts 800 – 1299 Safe Medical Devices Act (1990) FDA Modernization Act (1997)

12 What is a medical device? Diagnosis, cure, mitigation, treatment or prevention of disease or condition Affects the structure and function of the body Does not achieve intended use through chemical reaction Is not metabolized

13 Device Classification 1700 generic types of devices Three Classes - Class I - Class II - Class III intended use; intended user Classification determines extent of regulatory control

14 Device Classification Class I - General Controls Class II - General Controls and Special Controls Class III - General Controls and Premarket Approval Risk Low Medium High

15 Premarket approval – 510k Marketing for first time, or significant change to existing device Demonstration of Substantial Equivalence (SE) to legally marketed device in U.S. SE means As safe and as effective - engineering - clinical outcome

16 Premarket approval – PMA Only applies to Class III devices - New device - Device found not substantially equivalent Proof of safety and effectiveness with clinical data Investigational Device Exemption (IDE) may be desired or required

17 Investigational Device Exemption Used for clinical trials Significant risk devices Protection of human subjects Allows sponsor to recoup R&D costs

18 FDAs Framework -- The traditional strategy Regulatory gatekeeper Unilateral responsibilities Reactive orientation

19 FDAs Framework -- The emerging strategy Multifaceted, information-based strategy Collaborative multi-party harmonization Anticipatory orientation

20 eHealth Technology Issues Whats a Device? Whats a Device? Labeling Labeling Smart Devices Smart Devices Tele-health Tele-health Interacting Systems of Devices Interacting Systems of Devices Architectural Considerations Architectural Considerations Environmental Factors Environmental Factors

21 Action Groupings Public health issues NEGLIGIBLESIGNIFICANT Regulatory mandate NEGLIGIBLE SIGNIFICANT NO ACTION EDUCATION INFORMATION COLLABORATIONS MINIMALISM POLICY REQUIREMENTS - NEW - UPDATED


Download ppt "Office of Science and Technology Center for Devices and Radiological Health, FDA William A. Herman eHealth Technologies and the FDA."

Similar presentations


Ads by Google